GeneDx
Jessica Yan has extensive experience in commercial operations and strategy within the genetic testing industry, currently serving as the Head of Commercial Operations & Strategy at GeneDx since October 2021. Prior roles include similar leadership positions at Invitae and operational responsibilities in sales operations and analytics. Jessica has a strong background in sales and technical consulting from her time at Ambry Genetics and Denville Scientific, where contributions included promoting genetic testing services and providing high-quality research products. Earlier experience in neuroscience research at the University of North Carolina involved significant contributions to studies on neuronal development, along with training and supervising undergraduates and new research personnel. Jessica holds a Bachelor of Science in Biology from the University of North Carolina at Chapel Hill.
This person is not in any teams
This person is not in any offices
GeneDx
10 followers
GeneDx is focused on delivering personalized, actionable insights that improve health outcomes. We sit at the intersection of diagnostics and data science, pairing decades of genomic expertise with an unmatched ability to interpret clinical data at scale. Our exome and genome testing is among the best in the industry. We expect that it will be even more advanced in the future with the help of Centrellis®, our innovative health information platform. Powered by millions of medical records, Centrellis® integrates digital tools with artificial intelligence to ingest and synthesize clinical and genomic data. As a result of our robust test menu, including our exome and genome testing, and the comprehensive insights generated by Centrellis®, we are developing a more complete understanding of complex disease than ever before. This translates to faster diagnosis, more effective treatment plans, and enhanced drug discovery. Our offerings help a whole spectrum of healthcare partners -- clinicians, researchers, health systems, pharmaceutical companies, and payors -- improve patient experiences and advance population health.